Atlas Trials

Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Breast Cancer Patients Sensitive to Hormonal Therapy

Clinical trial NCT02411344 · COMPLETED

Trial details

NCT number
NCT02411344
Sponsor
Istituto Oncologico Veneto IRCCS
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endocrine Sensitive HER2+/HR+ Breast Cancer
Start date
2014-02-01
Primary completion
2018-01-12
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.